February 19, 2014

Consumers are increasingly performing omnichannel shopping, and prefer personalized offers across the different channels they shop, according to a new survey.

February 19, 2014

Wet n Wild and global beauty ambassador Fergie have unveiled the next evolution of the Fergie CenterStage Collection by Wet n Wild.

February 19, 2014

DiversityBusiness.com earlier this month named the “Top 50 Organizations for Multicultural Business Opportunities."

February 19, 2014

The West Virginia Senate on Tuesday voted 25-to-9 to make pseudoephedrine a Schedule IV prescription drug and exempt medicines that can’t easily be diverted to methamphetamine, according to published reports.

February 18, 2014

Actavis and Forest Labs. announced that they have entered into a definitive agreement under which Actavis will acquire Forest for a combination of cash and equity valued at approximately $25 billion, or $89.48 per Forest share ($26.04 in cash and 0.3306 Actavis shares for each share of Forest common stock).

February 18, 2014

“No one gets paid unless patients improve adherence.”

February 18, 2014

The one-time $100 million asthma-relief brand Primatene may make a comeback to the marketplace after a more than two-year hiatus.

February 18, 2014

Horst M. Rechelbacher, the founder of Aveda and a self-proclaimed “student” of nature, died on Feb. 15 at his home in Osceola, Wis., after a battle with pancreatic cancer.

February 18, 2014

While flu activity declined slightly from the week prior, incidence of influenza-like illness rates remained above the national baseline for the week ended Feb. 8, the Centers for Disease Control and Prevention reported.

February 18, 2014

The celebrity fragrance trend continues to live on, and among the latest entrants is singer and songwriter Enrique Iglesias.

February 18, 2014

Celestial Seasonings, a Hain Celestial Group brand, announced the introduction of its new line of organic and Fair Trade Certified Estate Teas.

February 18, 2014

Coca-Cola is rolling out its Dasani Sparkling line, five naturally flavored, unsweetened and lightly carbonated waters.

February 18, 2014

Recent strategic business initiatives are granting wholesalers more generic drug purchasing power than ever before.

February 18, 2014

Coty and Piaggio Group, a European manufacturer of two-wheel motor vehicles, have teamed up for an exclusive partnership to create, develop and distribute a signature duo of fragrances for men and women under the Vespa name.

February 18, 2014

This year, ECRM celebrates 20 years of successfully pairing buyers and sellers across the consumer packaged goods industry.

February 18, 2014

Credit Suisse on Tuesday speculated that Safeway may be considering either a sale or acquisition.

February 18, 2014

Diplomat Specialty Pharmacy on Monday announced that it has initiated a content partnership with the National Association of Specialty Pharmacy.

February 18, 2014

Roxane Labs on Tuesday announced the introduction of doxercalciferol capsules, available in strengths of 0.5-mcg, 1-mcg, and 2.5-mcg in 50-count bottles for immediate shipment to wholesalers and pharmacies across the nation.

February 18, 2014

In a blog post updated Friday, Food and Drug Administration commissioner Margaret Hamburg addressed two challenges facing Indian drug manufacturers — approval times for abbreviated new drug applications and quality inspections.

February 18, 2014

Canada Dry Ginger Ale has long been a staple in the flavored soft drink category.

February 18, 2014

Hy-Vee announced that it has entered into an agreement to purchase Amber Pharmacy, a specialty pharmacy solutions provider based in Omaha, Neb.

February 18, 2014

Despite declining sales, three category trends — sparkling water, natural sodas and low-calorie sodas — are keeping some fizz in carbonated soft drinks.

February 18, 2014

Now that most generics have declined in cost, plans will look for new ways to control health spend and ensure that generics are being used whenever possible.

February 18, 2014

From 2012 to 2017, global spending on medicines will increase from $205 billion to $235 billion, according to IMS Health. By 2017, 36% of the spend will be on generics, a number that is 9% more than the percentage in 2013.